Patents Assigned to LifeCodexx
  • MEANS AND METHODS FOR NON-INVASIVE DIAGNOSIS OF CHROMOSOMAL ANEUPLOIDY
    Publication number: 20170363628
    Abstract: The invention relates to a prenatal diagnostic method for the determination of a fetal chromosomal aneuploidy in a biological sample obtained from a pregnant woman, which method comprises enrichment and quantification of selected cell-free deoxyribonucleic acid sequences showing consensus nucleosome binding regions.
    Type: Application
    Filed: September 6, 2017
    Publication date: December 21, 2017
    Applicant: LifeCodexx
    Inventors: Marcus BENZ, Wera HOFMANN, Thomas POHL, Christoph Von KALLE
  • Means and methods for non-invasive diagnosis of chromosomal aneuploidy
    Patent number: 9784742
    Abstract: The invention relates to a prenatal diagnostic method for the determination of a fetal chromosomal aneuploidy in a biological sample obtained from a pregnant woman, which method comprises enrichment and quantification of selected cell-free deoxyribonucleic acid sequences showing consensus nucleosome binding regions.
    Type: Grant
    Filed: October 26, 2010
    Date of Patent: October 10, 2017
    Assignee: LifeCodexx
    Inventors: Marcus Benz, Wera Hofmann, Thomas Pohl, Christoph Von Kalle